查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
干细胞市场：规模、份额、趋势分析报告：副产品（成人干细胞、人类胚胎干细胞）、应用、技术、治疗、最终用途、地区、细分市场预测，2022-2030 年
市场调查报告书
商品编码
1147480

干细胞市场：规模、份额、趋势分析报告：副产品（成人干细胞、人类胚胎干细胞）、应用、技术、治疗、最终用途、地区、细分市场预测，2022-2030 年

Stem Cells Market Size, Share & Trends Analysis Report By Product (Adult Stem Cells, Human Embryonic Stem Cells), By Application, By Technology, By Therapy, By End Use, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

干细胞市场增长和趋势

根据 Grand View Research, Inc. 的最新报告，到 2030 年，全球干细胞市场规模预计将达到 316 亿美元，2022 年至 2030 年的复合年增长率为 11.4%。干细胞是可以分化成各种其他细胞并最终形成器官和组织的细胞。多年来进行了许多研究来评估干细胞的真正潜力，从而在遗传疾病治疗、神经系统疾病、肿瘤和器官再生等领域产生了各种应用。银行数量的增加、对增强这些产品的治疗潜力的日益关注以及对再生医学发展的广泛研究推动了市场的发展。

对再生医学日益增长的兴趣正在推动市场扩张。 iPS 细胞越来越受欢迎，因为它们被用于创建定制的细胞疗法并为再生医学开闢了新的可能性。例如，2020 年 9 月，杜克国立大学和莫纳什大学的研究人员发现了第一个可以帮助治疗妊娠期胎盘问题的干细胞。研究人员设计了一种生产人造绒毛干细胞的新方法，该干细胞可用于产生胎盘细胞。这项研究将有助于开发体外人胎盘模型，并为未来的治疗铺平道路。

此外，COVID-19 正在充当促进市场增长的催化剂。包括美国、中国和伊朗在内的几个国家已经开始进行使用细胞疗法治疗 COVID-19 感染的临床试验。此外，使用细胞疗法治疗 COVID-19 患者取得了优异的效果，这正在推动市场扩张。 2020 年 1 月，中国北京的一个研究小组进行了一项患者试验，以了解干细胞疗法是否对 COVID-19 有益。该研究发现，在第一次治疗试验期间，向 COVID-19 患者静脉注射临床级 MSCs 可改善功能结果并加速康復。

癌症患病率的增加是导致预测期内增长的关键因素之一。联合疗法和化学疗法在癌症治疗中的失败导致医生从这些方式转向自体和同种异体干细胞疗法，从而促进生长。此外，主要市场参与者和政府机构继续投资于癌症研究。例如，2021年11月，加州再生医学研究所将投资400万美元用于治疗急性淋巴细胞白血病（ALL）、慢性淋巴细胞白血病（CLL）和套细胞淋巴瘤（MCL）患者。

用于使用和采用基于细胞的疗法的新技术的引入预计将在预测期内推动增长。成人干细胞和脐带血处理和储存的自动化是一项关键技术，有望对市场增长产生积极影响。例如，许多科学家正在寻求批准使用干细胞治疗多种疾病的安全且成功的方法。 2021 年，Biotech Cellino 等公司将投资 7500 万美元，努力融合人工智能技术以开发自动化干细胞製造，旨在以经济高效的方式标准化细胞疗法的获取。

另一方面，高昂的治疗费用预计会阻碍市场增长。例如，干细胞研究公司 Bioinformant 报告称，每位患者的干细胞治疗费用在 5,000 美元到 8,000 美元之间，在某些情况下超过 25,000 美元，具体取决于手术的复杂程度。此外，对干细胞研究活动的限制传统上阻碍了胚胎干细胞的生长，导致儘管它们具有优势，但整体市场份额很小。

干细胞市场报告亮点

被认为是干细胞治疗黄金标准的 ASCs 领域在 2021 年占据了最大份额。一致的临床成功，特别是在造血干细胞移植方面，已导致广泛接受并且关于其来源的争议相对较少。

从 2022 年到 2030 年，iPSC 预计将以復合年增长率增长。这是因为越来越多的公司正在使用 iPS 进行细胞治疗。例如，2020 年 7 月，Cynata Therapeutics Limited 宣布了其旗舰产品 iPS 细胞衍生的 Cymerus CYP-001的一期临床试验的积极结果。

由于政府增加了对再生医学发展的资助，再生医学在 2021 年占据了市场主导地位。例如，2020 年 10 月，AusBiotech 牵头的财团从 MTPConnect 的 Industry Growth Center Project Fund 获得了 30 万美元的资助，用于澳大利亚的再生医学发展

细胞收穫技术将在 2021 年占据最大的市场份额，并且由于涉及细胞收穫的研究调查不断增加，预计从 2022 年到 2030 年将以最快的复合年增长率增长

由于异基因干细胞移植在癌症治疗中的增加，2021年异基因疗法将主导市场

製药和生物技术公司将在 2021 年占据最大的市场份额，并且由于研发活动的增加、临床试验的增加以及主要参与者的战略行动，预计将以最快的复合年增长率增长。

北美市场包括美国和加拿大。该地区的市场增长是由强大的政府资金、不断增加的研究以及该地区领先企业的存在推动的。

由于主要参与者的业务扩张，预计从 2022 年到 2030 年，亚太地区将以最快的复合年增长率增长。例如，2020 年 4 月，Seneca Biopharma 在中国苏州完成了一个新的干细胞製造工厂。

内容

第 1 章：研究技术

  • 市场细分和范围
  • 调查技术
  • 信息采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要信息
    • 初步调查
    • 初步调查的详细信息
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 模型详细信息
    • 商品流分析
      • 方法 1：商品流方法
      • 方法 2：使用自下而上的方法逐个国家/地区进行市场估算
  • 全球市场：CAGR 计算
  • 调查假设
  • 二级信息列表
  • 主要信息列表
  • 目的
  • 缩写列表

第二章市场定义

第 3 章执行摘要

  • 市场概览

第 4 章全球干细胞市场市场：变量、趋势和范围

  • 干细胞市场谱系展望
    • 母公司市场展望
  • 描绘渗透率和增长前景
  • 监管框架
  • 市场驱动因素分析
    • 再生医学的发展
    • 增加资金以加速干细胞研究
    • 对干细胞银行业务的需求不断增长
    • 遗传病患病率增加
  • 市场製约因素分析
    • 关于干细胞研究的伦理问题
    • 缺乏针对干细胞特定用途的明确监管框架
  • 主要机会
    • 对细胞和基因疗法的需求
  • 主要问题
    • 与製造过程相关的技术限制
  • 干细胞市场 - PESTLE 分析
  • 行业分析 - 搬运工
  • 对主要交易和战略联盟的分析
    • 合资企业
    • 併购
    • 许可和合作伙伴关係
    • 技术合作
    • 战略销售
  • COVID-19 影响分析

第 5 章干细胞市场：细分分析，按产品分类，2018-2030 年（百万美元）

  • 全球干细胞市场：产品波动分析
  • 成体干细胞 (ASC)
    • 造血干细胞（血液干细胞）
    • 间充质干细胞
    • 神经干细胞
    • 上皮/皮肤干细胞
    • 其他成体干细胞
  • 人类胚胎干细胞
  • 诱导多能干细胞
  • 非常小的类胚胎干细胞

第 6 章干细胞市场：细分分析，按应用，2018-2030（百万美元）

  • 干细胞市场：应用的变化分析
  • 再生医学
    • 神经学
    • 骨科
    • 肿瘤科
    • 血液学
    • 心血管和心肌梗塞
    • 受伤
    • 糖尿病
    • 肝损伤
    • 尿失禁
    • 其他
  • 药物发现和开发

第 7 章干细胞市场：细分分析，按技术，2018-2030 年（百万美元）

  • 全球干细胞市场：技术波动分析
  • 获取单元格
    • 骨髓采集
    • 脐带血
    • 单采术
  • 细胞生产
    • 治疗性克隆
    • 体外受精
    • 细胞培养
    • 隔离
  • 冷冻保存
  • 扩张和亚文化

第 8 章干细胞市场：按疗法细分分析，2018-2030（百万美元）

  • 全球干细胞市场：治疗波动分析
  • 首页
  • 同种异体

第 9 章干细胞市场：细分分析，按最终用户，2018-2030 年（百万美元）

  • 全球干细胞市场：最终用户波动分析
  • 製药和生物技术公司
  • 医院和细胞库
  • 学术和研究机构

第 10 章干细胞市场：按地区划分的细分分析，2018-2030 年（百万美元）

  • 干细胞市场：区域差异分析
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳大利亚
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国

第11章竞争格局

  • 上市公司
    • 公司市场分析
    • 竞争仪表板分析
    • 战略框架
  • 私人公司
    • 主要初创企业/技术颠覆者/创新者名单
    • 本地网络网络地图
  • 公司简介
    • ADVANCED CELL TECHNOLOGY, INC.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • STEMCELL Technologies, Inc.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • CELLULAR ENGINEERING TECHNOLOGIES INC.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • CELLGENIX GmbH
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • PROMOCELL GMBH
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • LONZA
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • KITE PHARMA
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • CELLARTIS AB
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • ANGEL BIOTECHNOLOGY
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • BRAINSTORM CELL THERAPEUTICS
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • CELGENE CORPORATION
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • OSIRIS THERAPEUTICS, INC.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • GENEA BIOCELLS
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • BIOHEART INC.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • WAISMAN BIOMANUFACTURING
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • TIGENIX
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • CALADRIUS
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • GAMIDA CELL.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • PLURISTEM THERAPEUTICS INC.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
Product Code: 978-1-68038-130-6

Stem Cells Market Growth & Trends:

The global stem cells market size is expected to reach USD 31.6 billion by 2030, registering a CAGR of 11.4% from 2022 to 2030, according to a new report by Grand View Research, Inc. Stem cells are cells that can differentiate into a variety of other cells, eventually forming organs or tissues. Many studies have been conducted over the years to assess the true potential of stem cells, leading to a variety of applications in the fields of genetic disease treatment, neurological disorders, oncology, and organ regeneration. The market is driven by the rising number of banks, growing focus on increasing therapeutic potential of these products, and extensive research for the development of regenerative medicines, among other factors.

The growing focus on regenerative therapies is fueling market expansion. iPSCs are becoming increasingly popular for the creation of customized cellular therapies, and opening up new possibilities in regenerative medicine. For instance, in September 2020, researchers from Duke-NUS and Monash University discovered the first stem cell that can aid in the treatment of placenta issues during pregnancy. The researchers devised a new method for producing induced trophoblast stem cells that can be used to generate placenta cells. The research will aid in the development of an in-vitro human placenta model and pave the way for future therapies.

Moreover, COVID-19 is acting as a catalyst for promoting the market growth. Several countries such as U.S., China, and Iran, have started conducting clinical trials using cellular therapies for treatment of COVID-19 infections. Furthermore, the use of cell therapy in the treatment of COVID-19 patients has yielded excellent results, which is fueling market expansion. In January 2020, a group of researchers in Beijing, China, tested stem cell treatment on patients to see if it was beneficial against COVID-19. The study found that administering intravenous clinical-grade MSCs to COVID-19 patients during first trial of treatment, improved their functional results and promoted enhanced recovery.

Increasing prevalence of cancer is one of the key factors contributing to the growth over the forecast period. Failure of combination therapy and chemotherapy for treatment of cancer has led to the shift in preference of physicians from such therapies to autologous and allogeneic stem cell therapy, thereby boosting the growth. Moreover, key market players and the government bodies are continuously investing in cancer research. For instance, in November 2021, California Institute for Regenerative Medicine invested USD 4 million in therapy targeting patients with acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL)

Introduction of novel technologies for the usage and adoption of cell based therapy is expected to boost the growth over the forecast period. Automation in adult stem cell & cord blood processing and storage are the key technologies expected to positively influence the market growth. For instance, various scientists are aiming for the approval of safe, and successful treatments using stem cells in a broad range of diseases. In 2021, companies such as Biotech Cellino invested USD 75 million in an effort to merge Artificial Intelligence technology for the development of automated stem cell manufacturing, that has the ability to regularizing access to cell treatments while aiming to be cost effective.

On the other hand, high cost of therapy is expected to hinder the market growth. For example, Bio informant, a stem cell research firm, reported that the cost of stem cell therapy ranges between USD 5,000 and USD 8,000 per patient, with some cases costing as much as USD 25,000 or more depending on the complexity of the procedure. Furthermore, restrictions on stem cell research activities have traditionally hampered embryonic stem cell growth, resulting in a meager share of the total market despite its advantages.

Stem Cells Market Report Highlights:

  • ASCs segment accounted for the largest share in 2021 as it is considered as a gold standard in stem cell-based therapies. They are widely accepted owing to their consistent clinical success especially in hematopoietic transplants and there is a relatively less controversial view regarding their origin
  • The iPSC segment is expected to witness a lucrative CAGR through 2022-2030 owing to the increasing focus of companies in using iPS for cell therapies. For instance, in July 2020, Cynata Therapeutics Limited announced positive results for the phase 1 clinical trial of CYP-001, the company's lead iPSC derived Cymerus
  • Regenerative medicine dominated the market in 2021 owing to increasing funding by the government for the development of regenerative medicines. For instance, in October 2020, the AusBiotech-led consortium received funding of USD 300,000 from MTPConnect's Industry Growth Centre Project Fund for the development of regenerative medicines in Australia
  • Cell acquisition technology held the largest market share in 2021 and is expected to expand at the fastest CAGR through 2022-2030 owing to increasing research studies involving cell harvesting
  • Allogenic therapy dominated the market in 2021 owing to the increasing application of allogeneic stem cell transplants for cancer treatment
  • Pharmaceutical and biotechnology companies held the largest market share in 2021, and is anticipated to exhibit at fastest CAGR owing to upsurge in R&D, increasing clinical trials coupled with strategic activities by major market players
  • North America market encompasses U.S. and Canada. The factors contributing to the market growth in the region include robust government funding, increasing research, and the presence of prominent players in this region
  • Asia Pacific is expected to grow with the fastest CAGR of through 2022 to 2030 owing to increasing expansion by key companies in this region. For instance, in April 2020, Seneca Biopharma completed its new stem cell manufacturing facility in Suzhou, China

Table of Contents

Chapter 1 Research Technologyology

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Technologyology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity flow approach
      • 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Research Assumptions
  • 1.9 List of Secondary Sources
  • 1.10 List of Primary Sources
  • 1.11 Objectives
    • 1.11.1 Objective 1:
    • 1.11.2 Objective 2:
  • 1.12 List Of Abbreviations

Chapter 2 Market Definitions

Chapter 3 Executive Summary

  • 3.1 Market Summary

Chapter 4 Global Stem Cells Market Market Variables, Trends, & Scope

  • 4.1 Stem Cells Market Lineage Outlook
    • 4.1.1 Parent Market Outlook
  • 4.2 Penetration and Growth Prospect Mapping
  • 4.3 Regulatory Framework
  • 4.4 Market Driver Analysis
    • 4.4.1 Ongoing Developments In Regenerative Medicine
    • 4.4.2 Rising Funds For Accelerating Stem Cell Research
    • 4.4.3 Growing Demand For Stem Cell Banking
    • 4.4.4 Increasing Prevalence Of Genetic Disorders
  • 4.5 Market Restraint Analysis
    • 4.5.1 Ethical Concern Related To Stem Cell Research
    • 4.5.1 Lack Of A Well-Defined Regulatory Framework In Certain Applications Of Stem Cell
  • 4.6 Key Opportunities
    • 4.6.1 Demand For Cell & Gene Therapies
  • 4.7 Key Challenge
    • 4.7.1 Technical Limitations Associated With Manufacturing Processes
  • 4.8 Stem Cells Market - Pestle Analysis
  • 4.9 Industry Analysis - Porter's
  • 4.10 Major Deals And Strategic Alliances Analysis
    • 4.10.1 Joint Ventures
    • 4.10.2 Mergers And Acquisitions
    • 4.10.3 Licensing And Partnership
    • 4.10.4 Technology Collaborations
    • 4.10.5 Strategic Divestments
  • 4.11 COVID-19 Impact Analysis

Chapter 5 Stem Cells Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)

  • 5.1 Global Stem Cells Market: Product Movement Analysis
  • 5.2 Adult Stem Cells (ASCs)
    • 5.2.1 Adult Stem Cells (Ascs) Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.2.2 Hematopoietic Stem Cells (Blood Stem Cells)
      • 5.2.2.1 Hematopoietic stem cells (blood stem cells) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.2.3 Mesenchymal Stem Cells
      • 5.2.3.1 Mesenchymal stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.2.4 Neural Stem Cells
      • 5.2.4.1 Neural stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.2.5 Epithelial/Skin Stem Cells
      • 5.2.5.1 Epithelial/Skin stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.2.6 Other Adult Stem Cells
      • 5.2.6.1 Other adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.3 Human Embryonic Stem Cells
    • 5.3.1 Human Embryonic Stem Cells Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.4 Induced Pluripotent Stem Cells
    • 5.4.1 Induced Pluripotent Stem Cells Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.5 Very Small Embryonic Like Stem Cells
    • 5.5.1 Very Small Embryonic Like Stem Cells Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 Stem Cells Market- Segment Analysis, by Application, 2018 - 2030 (USD Million)

  • 6.1 Stem Cells Market: Application Movement Analysis
  • 6.2 Regenerative Medicine
    • 6.2.1 Regenerative Medicine Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2 Neurology
      • 6.2.2.1 Neurology market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.3 Orthopedics
      • 6.2.3.1 Orthopedics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.4 Oncology
      • 6.2.4.1 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.5 Hematology
      • 6.2.5.1 Hematology market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.6 Cardiovascular and Myocardial Infraction
      • 6.2.6.1 Cardiovascular and myocardial infraction market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.7 Injuries
      • 6.2.7.1 Injuries market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.8 Diabetes
      • 6.2.8.1 Diabetes market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.9 Liver Disorder
      • 6.2.9.1 Liver Disorder market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.10 Incontinence
      • 6.2.10.1 Incontinence market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.11 Others
      • 6.2.11.1 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.3 Drug Discovery and Development
    • 6.3.1 Drug Discovery And Development Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 Stem Cells Market - Segment Analysis, by Technology, 2018 - 2030 (USD Million)

  • 7.1 Global Stem Cells Market: Technology Movement Analysis
  • 7.2 Cell Acquisition
    • 7.2.1 Cell Acquisition Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.2 Bone Marrow Harvest
      • 7.2.2.1 Bone Marrow Harvest market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.2.3 Umbilical Blood Cord
      • 7.2.3.1 Umbilical Blood Cord market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.2.4 Apheresis
      • 7.2.4.1 Apheresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.3 Cell Production
    • 7.3.1 Cell Production Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.3.2 Therapeutic Cloning
      • 7.2.3.1 Therapeutic Cloning market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.3 In Vitro Fertilization
      • 7.3.3.1 In Vitro Fertilization market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.4 Cell Culture
      • 7.3.4.1 Cell Culture market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.5 Isolation
      • 7.3.5.1 Isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4 Cryopreservation
    • 7.4.1 Cryopreservation Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.5 Expansion And Sub-Culture
    • 7.5.1 Expansion And Sub-Culture Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 Stem Cells Market - Segment Analysis, By Therapy, 2018 - 2030 (USD Million)

  • 8.1 Global Stem Cells Market: Therapy Movement Analysis
  • 8.2 Autologous
    • 8.2.1 Autologous Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.3 Allogenic
    • 8.3.1 Allogenic Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 9 Stem Cells Market - Segment Analysis, By End-User, 2018 - 2030 (USD Million)

  • 9.1 Global Stem Cells Market: End-User Movement Analysis
  • 9.2 Pharmaceutical And Biotechnology Companies
    • 9.2.1 Pharmaceutical And Biotechnology Companies Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 9.3 Hospitals & Cell Banks
    • 9.3.1 Hospitals & Cell Banks Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 9.4 Academic & Research Institutes
    • 9.4.1 Academic & Research Institutes Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 10 Stem Cells Market: - Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 10.1 Stem Cells Market: Regional Movement Analysis
  • 10.2 North America
    • 10.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.2.2 U.S.
      • 10.2.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 10.2.3 Canada
      • 10.2.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 10.3 Europe
    • 10.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.3.2 U.K.
      • 10.3.2.1 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
    • 10.3.3. Germany
      • 10.3.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 10.3.4 France
      • 10.3.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
    • 10.3.5. Italy
      • 10.3.5.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 10.3.5 Spain
      • 10.3.5.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • 10.4 Asia Pacific
    • 10.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.4.2 Japan
      • 10.4.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 10.4.3 China
      • 10.4.3.1 China market estimates and forecast, 2018 - 2030 (USD Million)
    • 10.4.4 India
      • 10.4.4.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.4.5 South Korea
      • 10.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.4.6 Australia
      • 10.4.6.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 10.5 Latin America
    • 10.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.5.2 Brazil
      • 10.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.5.3 Mexico
      • 10.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.5.4 Argentina
      • 10.5.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 10.6 Middle East & Africa (MEA)
    • 10.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.6.1 South Africa
      • 10.6.1.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.6.2 Saudi Arabia
      • 10.6.2.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 10.6.3 UAE
      • 10.6.3.1 UAE market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 11 Competitive Landscape

  • 11.1 Public Companies
    • 11.1.1 Company Market Position Analysis
    • 11.1.2 Competitive Dashboard Analysis
    • 11.1.3 Strategic Framework
  • 11.2 Private Companies
    • 11.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
    • 11.2.2 Regional Network Map
  • 11.3 Company Profiles
    • 11.3.1 ADVANCED CELL TECHNOLOGY, INC.
      • 11.3.1.1 Company Overview
      • 11.3.1.2 Financial Performance
      • 11.3.1.3 Product Benchmarking
      • 11.3.1.4 Strategic Initiatives
    • 11.3.2 STEMCELL Technologies, Inc.
      • 11.3.2.1 Company Overview
      • 11.3.2.2 Financial Performance
      • 11.3.2.3 Product Benchmarking
      • 11.3.2.4 Strategic Initiatives
    • 11.3.3 CELLULAR ENGINEERING TECHNOLOGIES INC.
      • 11.3.3.1 Company Overview
      • 11.3.3.2 Financial Performance
      • 11.3.3.3 Product Benchmarking
      • 11.3.3.4 Strategic Initiatives
    • 11.3.4 CELLGENIX GmbH
      • 11.3.4.1 Company Overview
      • 11.3.4.2 Financial Performance
      • 11.3.4.3 Product Benchmarking
      • 11.3.4.4 Strategic Initiatives
    • 11.3.5 PROMOCELL GMBH
      • 11.3.5.1 Company Overview
      • 11.3.5.2 Financial Performance
      • 11.3.5.3 Product Benchmarking
      • 11.3.5.4 Strategic Initiatives
    • 11.3.6 LONZA
      • 11.3.6.1 Company Overview
      • 11.3.6.2 Financial Performance
      • 11.3.6.3 Product Benchmarking
      • 11.3.6.4 Strategic Initiatives
    • 11.3.7 KITE PHARMA
      • 11.3.7.1 Company Overview
      • 11.3.7.2 Financial Performance
      • 11.3.7.3 Product Benchmarking
      • 11.3.7.4 Strategic Initiatives
    • 11.3.8 CELLARTIS AB
      • 11.3.8.1 Company Overview
      • 11.3.8.2 Financial Performance
      • 11.3.8.3 Product Benchmarking
      • 11.3.8.4 Strategic Initiatives
    • 11.3.9 ANGEL BIOTECHNOLOGY
      • 11.3.9.1 Company Overview
      • 11.3.9.2 Financial Performance
      • 11.3.9.3 Product Benchmarking
      • 11.3.9.4 Strategic Initiatives
    • 11.3.10 BRAINSTORM CELL THERAPEUTICS
      • 11.3.10.1 Company Overview
      • 11.3.10.2 Financial Performance
      • 11.3.10.3 Product Benchmarking
      • 11.3.10.4 Strategic Initiatives
    • 11.3.11 CELGENE CORPORATION
      • 11.3.11.1 Company Overview
      • 11.3.11.2 Financial Performance
      • 11.3.11.3 Product Benchmarking
      • 11.3.11.4 Strategic Initiatives
    • 11.3.12 OSIRIS THERAPEUTICS, INC.
      • 11.3.12.1 Company Overview
      • 11.3.12.2 Financial Performance
      • 11.3.12.3 Product Benchmarking
      • 11.3.12.4 Strategic Initiatives
    • 11.3.13 GENEA BIOCELLS
      • 11.3.13.1 Company Overview
      • 11.3.13.2 Financial Performance
      • 11.3.13.3 Product Benchmarking
      • 11.3.13.4 Strategic Initiatives
    • 11.3.14 BIOHEART INC.
      • 11.3.14.1 Company Overview
      • 11.3.14.2 Financial Performance
      • 11.3.14.3 Product Benchmarking
      • 11.3.14.4 Strategic Initiatives
    • 11.3.15 WAISMAN BIOMANUFACTURING
      • 11.3.15.1 Company Overview
      • 11.3.15.2 Financial Performance
      • 11.3.15.3 Product Benchmarking
      • 11.3.15.4 Strategic Initiatives
    • 11.3.16 TIGENIX
      • 11.3.16.1 Company Overview
      • 11.3.16.2 Financial Performance
      • 11.3.16.3 Product Benchmarking
      • 11.3.16.4 Strategic Initiatives
    • 11.3.17 CALADRIUS
      • 11.3.17.1 Company Overview
      • 11.3.17.2 Financial Performance
      • 11.3.17.3 Product Benchmarking
      • 11.3.17.4 Strategic Initiatives
    • 11.3.18 GAMIDA CELL.
      • 11.3.18.1 Company Overview
      • 11.3.18.2 Financial Performance
      • 11.3.18.3 Product Benchmarking
      • 11.3.18.4 Strategic Initiatives
    • 11.3.19 PLURISTEM THERAPEUTICS INC.
      • 11.3.19.1 Company Overview
      • 11.3.19.2 Financial Performance
      • 11.3.19.3 Product Benchmarking
      • 11.3.19.4 Strategic Initiatives

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Global Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 4 Global Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 5 Global Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 6 Global Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 7 Global Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 8 Global Stem Cells Market, by Region, 2018 - 2030 (USD Million)
  • TABLE 9 North America Stem Cells Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 10 North America Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 11 North America Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 12 North America Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 13 North America Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 14 North America Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 15 U.S. Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 16 U.S. Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 17 U.S. Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 18 U.S. Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 19 U.S. Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 20 Canada Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 21 Canada Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 22 Canada Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 23 Canada Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 24 Canada Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 25 Europe Stem Cells Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 26 Europe Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 27 Europe Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 28 Europe Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 29 Europe Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 30 Europe Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 31 Germany Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 32 Germany Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 33 Germany Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 34 Germany Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 35 Germany Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 36 U.K. Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 37 U.K. Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 38 U.K. Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 39 U.K. Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 40 U.K. Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 41 France Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 42 France Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 43 France Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 44 France Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 45 France Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 46 Italy Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 47 Italy Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 48 Italy Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 49 Italy Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 50 Italy Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 51 Spain Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 52 Spain Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 53 Spain Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 54 Spain Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 55 Spain Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 56 Asia Pacific Stem Cells Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 57 Asia Pacific Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 58 Asia Pacific Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 59 Asia Pacific Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 60 Asia Pacific Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 61 Asia Pacific Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 62 China Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 63 China Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 64 China Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 65 China Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 66 China Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 67 Japan Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 68 Japan Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 69 Japan Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 70 Japan Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 71 Japan Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 72 India Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 73 India Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 74 India Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 75 India Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 76 India Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 77 South Korea Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 78 South Korea Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 79 South Korea Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 80 South Korea Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 81 South Korea Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 82 Australia Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 83 Australia Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 84 Australia Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 85 Australia Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 86 Australia Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 87 Latin America Stem Cells Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 88 Latin America Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 89 Latin America Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 90 Latin America Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 91 Latin America Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 92 Latin America Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 93 Brazil Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 94 Brazil Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 95 Brazil Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 96 Brazil Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 97 Brazil Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 98 Mexico Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 99 Mexico Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 100 Mexico Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 101 Mexico Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 102 Mexico Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 103 Argentina Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 104 Argentina Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 105 Argentina Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 106 Argentina Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 107 Argentina Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 108 Middle East & Africa Stem Cells Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 109 Middle East & Africa Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 110 Middle East & Africa Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 111 Middle East & Africa Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 112 Middle East & Africa Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 113 Middle East & Africa Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 114 South Africa Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 115 South Africa Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 116 South Africa Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 117 South Africa Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 118 South Africa Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 119 Saudi Arabia Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 120 Saudi Arabia Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 121 Saudi Arabia Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 122 Saudi Arabia Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 123 Saudi Arabia Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 124 UAE Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 125 UAE Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 126 UAE Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 127 UAE Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 128 UAE Stem Cells Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information Procurement
  • FIG. 3 Primary Research Pattern
  • FIG. 4 Market Research Approaches
  • FIG. 5 Value Chain-Based Sizing & Forecasting
  • FIG. 6 Market Formulation & Validation
  • FIG. 7 Stem Cells Market Segmentation
  • FIG. 8 Market Snapshot, 2021
  • FIG. 9 Market Trends & Outlook
  • FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • FIG. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • FIG. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • FIG. 14 Porter's Five Forces Analysis
  • FIG. 15 Market Penetration Vs Growth Prospect Mapping, 2021
  • FIG. 16 Global Stem Cells Market: Product Movement Analysis
  • FIG. 17 Global Stem Cells Market, for Adult Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 18 Global Stem Cells Market, for Hematopoietic Stem Cells (Blood Stem Cells), 2018 - 2030 (USD Million)
  • FIG. 19 Global Stem Cells Market, for Mesenchymal Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 20 Global Stem Cells Market, for Neural Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 21 Global Stem Cells Market, for Epithelial/Skin Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 22 Global Stem Cells Market, for Other Adult Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 23 Global Stem Cells Market, for Human Embryonic Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 24 Global Stem Cells Market, for Induced Pluripotent Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 25 Global Stem Cells Market, for Very Small Embryonic Like Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 26 Global Stem Cells Market: Application Movement Analysis
  • FIG. 27 Global Stem Cells Market, for Regenerative Medicine, 2018 - 2030 (USD Million)
  • FIG. 28 Global Stem Cells Market, for Neurology, 2018 - 2030 (USD Million)
  • FIG. 29 Global Stem Cells Market, for Orthopedics, 2018 - 2030 (USD Million)
  • FIG. 30 Global Stem Cells Market, for Oncology, 2018 - 2030 (USD Million)
  • FIG. 31 Global Stem Cells Market, for Hematology, 2018 - 2030 (USD Million)
  • FIG. 32 Global Stem Cells Market, for Cardiovascular and Myocardial Infraction, 2018 - 2030 (USD Million)
  • FIG. 33 Global Stem Cells Market, for Injuries, 2018 - 2030 (USD Million)
  • FIG. 34 Global Stem Cells Market, for Diabetes, 2018 - 2030 (USD Million)
  • FIG. 35 Global Stem Cells Market, for Liver Disorder, 2018 - 2030 (USD Million)
  • FIG. 36 Global Stem Cells Market, for Incontinence, 2018 - 2030 (USD Million)
  • FIG. 37 Global Stem Cells Market, for Others, 2018 - 2030 (USD Million)
  • FIG. 38 Global Stem Cells Market, for Drug Discovery and Development, 2018 - 2030 (USD Million)
  • FIG. 39 Global Stem Cells Market: Technology Movement Analysis
  • FIG. 40 Global Stem Cells Market, for Cell Acquisition, 2018 - 2030 (USD Million)
  • FIG. 41 Global Stem Cells Market, for Bone Marrow Harvest, 2018 - 2030 (USD Million)
  • FIG. 42 Global Stem Cells Market, for Umbilical Blood Cord, 2018 - 2030 (USD Million)
  • FIG. 43 Global Stem Cells Market, for Apheresis, 2018 - 2030 (USD Million)
  • FIG. 44 Global Stem Cells Market, for Cell Production, 2018 - 2030 (USD Million)
  • FIG. 45 Global Stem Cells Market, for Therapeutic Cloning, 2018 - 2030 (USD Million)
  • FIG. 46 Global Stem Cells Market, for In Vitro Fertilization, 2018 - 2030 (USD Million)
  • FIG. 47 Global Stem Cells Market, for Cell Culture, 2018 - 2030 (USD Million)
  • FIG. 48 Global Stem Cells Market, for Isolation, 2018 - 2030 (USD Million)
  • FIG. 49 Global Stem Cells Market, for Cryopreservation, 2018 - 2030 (USD Million)
  • FIG. 50 Global Stem Cells Market, for Expansion and Sub-Culture, 2018 - 2030 (USD Million)
  • FIG. 51 Global Stem Cells Market: Therapy Movement Analysis
  • FIG. 52 Global Stem Cells Market, for Autologous, 2018 - 2030 (USD Million)
  • FIG. 53 Global Stem Cells Market, for Allogenic, 2018 - 2030 (USD Million)
  • FIG. 54 Global Stem Cells Market, End-User Movement Analysis
  • FIG. 55 Global Stem Cells Market, for Pharmaceutical and Biotechnology Companies, 2018 - 2030 (USD Million)
  • FIG. 56 Global Stem Cells Market, for Hospitals & Cell Banks, 2018 - 2030 (USD Million)
  • FIG. 57 Global Stem Cells Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
  • FIG. 58 Regional Marketplace: Key Takeaways
  • FIG. 59 Regional Outlook, 2021 & 2030
  • FIG. 60 Global Stem Cells Market: Region Movement Analysis
  • FIG. 61 North America Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 62 U.S. Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 63 Canada Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 64 Europe Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 65 Germany Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 66 U.K. Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 67 France Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 68 Italy Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 69 Spain Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 70 Asia Pacific Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 71 Japan Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 72 China Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 73 India Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 74 Australia Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 75 South Korea Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 76 Latin America Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 77 Brazil Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 78 Mexico Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 79 Argentina Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 80 Middle East and Africa Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 81 South Africa Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 82 Saudi Arabia Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 83 UAE Stem Cells Market, 2018 - 2030 (USD Million)